Amgen Inc (AMG.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 07:26PM CEST
| Previous close | 257.15 |
| Open | 293.00 |
| Bid | 287.40 x 200000 |
| Ask | 288.25 x 300000 |
| Day's range | 289.50 - 295.90 |
| 52-week range | 197.70 - 303.00 |
| Volume | |
| Avg. volume | 150 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
GuruFocus.comDecoding Amgen Inc (AMGN): A Strategic SWOT Insight
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
Barrons.comThese Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
© 2024 Yahoo. All rights reserved.